Acumen Pharmaceuticals Inc Cash Return on Investment (CROI) 2 year CAGR is 1.95% for the year ending December 31, 2023. The cash return on investment ratio measures the profitability of a company's total investments based on its operating cash flow. It is calculated by dividing operating cash flow by total investments. This ratio indicates how effectively the company generates cash flow from its investments. A higher ratio suggests more efficient cash flow generation from the investments made. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.